141 related articles for article (PubMed ID: 10643003)
1. Oncogene amplification in medulloblastoma: analysis of a case by comparative genomic hybridization and fluorescence in situ hybridization.
Jay V; Squire J; Bayani J; Alkhani AM; Rutka JT; Zielenska M
Pathology; 1999 Nov; 31(4):337-44. PubMed ID: 10643003
[TBL] [Abstract][Full Text] [Related]
2. MYCC and MYCN oncogene amplification in medulloblastoma. A fluorescence in situ hybridization study on paraffin sections from the Children's Oncology Group.
Aldosari N; Bigner SH; Burger PC; Becker L; Kepner JL; Friedman HS; McLendon RE
Arch Pathol Lab Med; 2002 May; 126(5):540-4. PubMed ID: 11958658
[TBL] [Abstract][Full Text] [Related]
3. Detection of oncogene amplifications in medulloblastomas by comparative genomic hybridization and array-based comparative genomic hybridization.
Tong CY; Hui AB; Yin XL; Pang JC; Zhu XL; Poon WS; Ng HK
J Neurosurg; 2004 Feb; 100(2 Suppl Pediatrics):187-93. PubMed ID: 14758948
[TBL] [Abstract][Full Text] [Related]
4. Outcome prediction in pediatric medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN loci.
Pfister S; Remke M; Benner A; Mendrzyk F; Toedt G; Felsberg J; Wittmann A; Devens F; Gerber NU; Joos S; Kulozik A; Reifenberger G; Rutkowski S; Wiestler OD; Radlwimmer B; Scheurlen W; Lichter P; Korshunov A
J Clin Oncol; 2009 Apr; 27(10):1627-36. PubMed ID: 19255330
[TBL] [Abstract][Full Text] [Related]
5. Molecular cytogenetic analysis of medulloblastomas and supratentorial primitive neuroectodermal tumors by using conventional banding, comparative genomic hybridization, and spectral karyotyping.
Bayani J; Zielenska M; Marrano P; Kwan Ng Y; Taylor MD; Jay V; Rutka JT; Squire JA
J Neurosurg; 2000 Sep; 93(3):437-48. PubMed ID: 10969942
[TBL] [Abstract][Full Text] [Related]
6. Genetic alterations in childhood medulloblastoma analyzed by comparative genomic hybridization.
Michiels EM; Weiss MM; Hoovers JM; Baak JP; Voûte PA; Baas F; Hermsen MA
J Pediatr Hematol Oncol; 2002; 24(3):205-10. PubMed ID: 11990307
[TBL] [Abstract][Full Text] [Related]
7. Episomal amplification of MYCN in a case of medulloblastoma.
Surace C; Pedeutour F; Trombetta D; Burel-Vandenbos F; Rocchi M; Storlazzi CT
Virchows Arch; 2008 May; 452(5):491-7. PubMed ID: 18286303
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive molecular cytogenetic investigation of chromosomal abnormalities in human medulloblastoma cell lines and xenograft.
Aldosari N; Wiltshire RN; Dutra A; Schrock E; McLendon RE; Friedman HS; Bigner DD; Bigner SH
Neuro Oncol; 2002 Apr; 4(2):75-85. PubMed ID: 11916498
[TBL] [Abstract][Full Text] [Related]
9. Application of a simplified comparative genomic hybridization technique to screen for gene amplification in pediatric solid tumors.
Bayani J; Thorner P; Zielenska M; Pandita A; Beatty B; Squire JA
Pediatr Pathol Lab Med; 1995; 15(6):831-44. PubMed ID: 8705194
[TBL] [Abstract][Full Text] [Related]
10. Large-cell medulloblastomas. A distinct variant with highly aggressive behavior.
Giangaspero F; Rigobello L; Badiali M; Loda M; Andreini L; Basso G; Zorzi F; Montaldi A
Am J Surg Pathol; 1992 Jul; 16(7):687-93. PubMed ID: 1530108
[TBL] [Abstract][Full Text] [Related]
11. [Correct use of Kreatech DNA probes to detect MYC gene amplification in medulloblastomas by fluorescence in situ hybridization].
Ryzhova MV; Snigireva GP; Golanov AV; Zheludkova OG; Trunin YY; Antipina NA
Arkh Patol; 2019; 81(4):66-72. PubMed ID: 31407721
[TBL] [Abstract][Full Text] [Related]
12. Comparative genomic hybridization of medulloblastomas and clinical relevance: eleven new cases and a review of the literature.
Gilhuis HJ; Anderl KL; Boerman RH; Jeuken JM; James CD; Raffel C; Scheithauer BW; Jenkins RB
Clin Neurol Neurosurg; 2000 Dec; 102(4):203-209. PubMed ID: 11154805
[TBL] [Abstract][Full Text] [Related]
13. Low-level copy number changes of MYC genes have a prognostic impact in medulloblastoma.
Zitterbart K; Filkova H; Tomasikova L; Necesalova E; Zambo I; Kantorova D; Slamova I; Vranova V; Zezulkova D; Pesakova M; Pavelka Z; Veselska R; Kuglik P; Sterba J
J Neurooncol; 2011 Mar; 102(1):25-33. PubMed ID: 20607354
[TBL] [Abstract][Full Text] [Related]
14. Large cell/anaplastic medulloblastomas and medullomyoblastomas: clinicopathological and genetic features.
Leonard JR; Cai DX; Rivet DJ; Kaufman BA; Park TS; Levy BK; Perry A
J Neurosurg; 2001 Jul; 95(1):82-8. PubMed ID: 11453402
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of medulloblastoma in children under age of three years.
Ryzhova MV; Zheludkova OG; Kumirova ÉV; Shishkina LV; Panina TN; Gorelyshev SK; Khukhlaeva EA; Mazerkina NA; Matuev KB; Medvedeva OA; Tarasova EM; Kholodov BV; Kapitul'skaia OIu
Zh Vopr Neirokhir Im N N Burdenko; 2013; 77(1):3-10; discussion 11. PubMed ID: 23659115
[TBL] [Abstract][Full Text] [Related]
16. Imbalances of chromosome 17 in medulloblastomas determined by comparative genomic hybridisation and fluorescence in situ hybridisation.
Nicholson J; Wickramasinghe C; Ross F; Crolla J; Ellison D
Mol Pathol; 2000 Dec; 53(6):313-9. PubMed ID: 11193050
[TBL] [Abstract][Full Text] [Related]
17. Glioblastoma occurring at the site of a previous medulloblastoma following a 5-year remission period.
Martin SE; Brat DJ; Vance GH; Stohler R; Choi H; Douglas-Akinwande AC; Hattab EM
Neuropathology; 2012 Oct; 32(5):543-50. PubMed ID: 22151431
[TBL] [Abstract][Full Text] [Related]
18. Multiple genomic alterations including N-myc amplification in a primary large cell medulloblastoma.
Reardon DA; Jenkins JJ; Sublett JE; Burger PC; Kun LK
Pediatr Neurosurg; 2000 Apr; 32(4):187-91. PubMed ID: 10940769
[TBL] [Abstract][Full Text] [Related]
19. MYC and MYCN amplification can be reliably assessed by aCGH in medulloblastoma.
Bourdeaut F; Grison C; Maurage CA; Laquerriere A; Vasiljevic A; Delisle MB; Michalak S; Figarella-Branger D; Doz F; Richer W; Pierron G; Miquel C; Delattre O; Couturier J
Cancer Genet; 2013 Apr; 206(4):124-9. PubMed ID: 23578955
[TBL] [Abstract][Full Text] [Related]
20. MYC family amplification and clinical risk-factors interact to predict an extremely poor prognosis in childhood medulloblastoma.
Ryan SL; Schwalbe EC; Cole M; Lu Y; Lusher ME; Megahed H; O'Toole K; Nicholson SL; Bognar L; Garami M; Hauser P; Korshunov A; Pfister SM; Williamson D; Taylor RE; Ellison DW; Bailey S; Clifford SC
Acta Neuropathol; 2012 Apr; 123(4):501-13. PubMed ID: 22139329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
